International Alzheimer’s Disease AD. World Alzheimer Report. 2023: Reducing Dementia Risk: Never too early, never too late. 2023 [cited 2024 Apr 1]; https://www.alzint.org/resource/world-alzheimer-report-2023/

WHO WHO. Dementia. WHO fact sheet on dementia. 2024 [cited 2024 Mar 11]. https://www.who.int/news-room/fact-sheets/detail/dementia

Comas-Herrera A, Guerchet M, Karagiannidou M, Knapp M, Prince M, World Alzheimer R. 2016: Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future. 2016 [cited 2024 Apr 1]; https://www.alzint.org/resource/world-alzheimer-report-2016/

International Alzheimer’s Disease. World Alzheimer Report 2015: The global impact of dementia: An analysis of prevalence, incidence, cost and trends. 2015 [cited 2024 Apr 1]; https://www.alzint.org/resource/world-alzheimer-report-2015/

International Alzheimer’s Disease. World Alzheimer Report 2021: Journey through the diagnosis of dementia. 2021 [cited 2024 Apr 1]; https://www.alzint.org/resource/world-alzheimer-report-2021/

Rasmussen J, Langerman H. Alzheimer’s disease – why we need early diagnosis. Degener Neurol Neuromuscul Dis. 2019;9:123–30.

PubMed  PubMed Central  Google Scholar 

London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9:44–53.

Article  PubMed  Google Scholar 

Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer’s disease. Brain Res. 1989;501:364–72.

Article  PubMed  Google Scholar 

Hinton David R, Sadun Alfredo A, Blanks Janet C, Miller Carol A. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med. 1986;315:485–7.

Article  Google Scholar 

Snyder PJ, Alber J, Alt C, Bain LJ, Bouma BE, Bouwman FH, et al. Retinal imaging in Alzheimer’s and neurodegenerative diseases. Alzheimers Dement. 2021;17:103–11.

Article  PubMed  Google Scholar 

Cheung CY-L, Ikram MK, Chen C, Wong TY. Imaging retina to study dementia and stroke. Prog Retin Eye Res. 2017;57:89–107.

Article  PubMed  Google Scholar 

Chan VTT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, et al. Spectral-domain OCT measurements in Alzheimer’s disease: a systematic review and meta-analysis. Ophthalmology. 2019;126:497–510.

Article  PubMed  Google Scholar 

den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer’s disease: a systematic review and meta-analysis. Alzheimers Dement (Amst). 2017;6:162–70.

Article  Google Scholar 

Jeevakumar V, Sefton R, Chan J, Gopinath B, Liew G, Shah TM, et al. Association between retinal markers and cognition in older adults: a systematic review. BMJ Open. 2022;12:e054657.

Article  PubMed  PubMed Central  Google Scholar 

Choi SH, Park SJ, Kim NR. Macular Ganglion cell -inner plexiform layer thickness is associated with clinical progression in mild cognitive impairment and alzheimers disease. PLoS ONE. 2016;11:e0162202.

Article  PubMed  PubMed Central  Google Scholar 

Kim HM, Han JW, Park YJ, Bae JB, Woo SJ, Kim KW. Association between retinal layer thickness and cognitive decline in older adults. JAMA Ophthalmol. 2022;140:683–90.

Article  PubMed  PubMed Central  Google Scholar 

Ko F, Muthy ZA, Gallacher J, Sudlow C, Rees G, Yang Q, et al. Association of retinal nerve fiber layer thinning with current and future cognitive decline: a study using optical coherence tomography. JAMA Neurol. 2018;75:1198–205.

Article  PubMed  PubMed Central  Google Scholar 

Méndez-Gómez JL, Rougier M-B, Tellouck L, Korobelnik J-F, Schweitzer C, Delyfer M-N et al. Peripapillary retinal nerve fiber layer thickness and the evolution of cognitive performance in an elderly population. Front Neurol. 2017 [cited 2024 Apr 11];8. https://www.frontiersin.org/journals/neurology/articles/https://doi.org/10.3389/fneur.2017.00093/full

Cheung CY, Wong WLE, Hilal S, Kan CN, Gyanwali B, Tham YC et al. Deep-learning retinal vessel calibre measurements and risk of cognitive decline and dementia. Brain Communications. 2022 [cited 2024 Mar 6];4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416061/

Xu X, Hilal S, Collinson SL, Chong EJY, Ikram MK, Venketasubramanian N, et al. Association of magnetic resonance imaging markers of cerebrovascular disease burden and cognition. Stroke. 2015;46:2808–14.

Article  PubMed  Google Scholar 

Kuźma E, Littlejohns TJ, Khawaja AP, Llewellyn DJ, Ukoumunne OC, Thiem U. Visual impairment, eye diseases, and dementia risk: a systematic review and meta-analysis. J Alzheimers Dis. 2021;83:1073–87.

Article  PubMed  Google Scholar 

Hilal S, Chai YL, Ikram MK, Elangovan S, Yeow TB, Xin X, et al. Markers of cardiac dysfunction in cognitive impairment and dementia. Med (Baltim). 2015;94:e297.

Article  Google Scholar 

Chai YL, Yeo HK-H, Wang J, Hilal S, Ikram MK, Venketasubramanian N, et al. Apolipoprotein ɛ4 is associated with dementia and cognitive impairment predominantly due to Alzheimer’s disease and not with vascular cognitive impairment: a Singapore-based cohort. J Alzheimers Dis. 2016;51:1111–8.

Article  PubMed  Google Scholar 

Srikrishna M, Ashton NJ, Moscoso A, Pereira JB, Heckemann RA, van Westen D, et al. CT-based volumetric measures obtained through deep learning: association with biomarkers of neurodegeneration. Alzheimers Dement. 2024;20:629–40.

Article  PubMed  Google Scholar 

Diagnostic. and statistical manual of mental disorders, 4th ed. Arlington, VA, US: American Psychiatric Publishing, Inc.; 1994. p. xxvii, 886.

Phua AKS, Hiu SKW, Goh WK, Ikram MK, Venketasubramanian N, Tan BY, et al. Low accuracy of brief cognitive tests in tracking longitudinal cognitive decline in an Asian Elderly Cohort. J Alzheimers Dis. 2018;62:409–16.

Article  PubMed  Google Scholar 

Wechsler D. Subtest Administration and Scoring. WAIS–IV: Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation;2009;87–93. San Antonio; 2009.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology. 1984;34:939–44.

Article  PubMed  Google Scholar 

D’Elia L, Satz P, Uchiyama C, White T. Color Trail Test. Color trails test. Professional Manual. Odessa, FL: Psychological Assessment Resources; 1996. pp. 1–38.

Google Scholar 

Mack WJ, Freed DM, Williams BW, Henderson VW. Boston naming test: shortened versions for use in Alzheimer’s disease. J Gerontol. 1992;47:P154–8.

Article  PubMed  Google Scholar 

Smith A. Symbol Digit modalities Test. Los Angeles, CA: Services WP; 1973. pp. 1–20.

Google Scholar 

Meyers J, Meyers K. Rey complex figure test and the recognition trial. Odessa, FL: Psychological Assessment Resources; 1994:1–81. 1994.

Brandt J. The hopkins verbal learning test: development of a new memory test with six equivalent forms. Clin Neuropsychologist. 1991;5:125–42.

Article  Google Scholar 

Hessen E, Eckerström M, Nordlund A, Selseth Almdahl I, Stålhammar J, Bjerke M, et al. Subjective cognitive impairment is a predominantly benign condition in memory clinic patients followed for 6 years: the Gothenburg-Oslo MCI study. Dement Geriatr Cogn Dis Extra. 2017;7:1–14.

Article  PubMed  PubMed Central  Google Scholar 

Wolinsky FD, Unverzagt FW, Smith DM, Jones R, Stoddard A, Tennstedt SL. The ACTIVE cognitive training trial and health-related quality of life: protection that lasts for 5 years. Journals Gerontology: Ser A. 2006;61:1324–9.

Article  Google Scholar 

Borland E, Edgar C, Stomrud E, Cullen N, Hansson O, Palmqvist S. Clinically relevant changes for cognitive outcomes in preclinical and prodromal cognitive stages: implications for clinical Alzheimer trials. Neurology. 2022;99:e1142–53.

Article  PubMed  PubMed Central  Google Scholar 

Rossetti HC, Munro Cullum C, Hynan LS, Lacritz LH. The CERAD neuropsychologic battery total score and the progression of Alzheimer disease. Alzheimer Dis Assoc Disord. 2010;24:138–42.

Article  PubMed  PubMed Central  Google Scholar 

Unger JM, van Belle G, Heyman A. Cross-sectional versus longitudinal estimates of cognitive change in nondemented older people: a CERAD study. Consortium to establish a Registry for Alzheimer’s Disease. J Am Geriatr Soc. 1999;47:559–63.

Article  PubMed  Google Scholar 

Chua J, Zhang Z, Wong D, Tan B, Kulantayan B, Sng CCA, et al. Age-related eye diseases in individuals with mild cognitive impairment and Alzheimer’s disease. Front Aging Neurosci. 2022;14:933853.

Article  PubMed  PubMed Central  Google Scholar 

Chua J, Li C, Ho LKH, Wong D, Tan B, Yao X, et al. A multi-regression framework to improve diagnostic ability of optical coherence tomography retinal biomarkers to discriminate mild cognitive impairment and Alzheimer’s disease. Alzheimers Res Ther. 2022;14:41.

Article  PubMed  PubMed Central  Google Scholar 

Mwanza J-C, Oakley JD, Budenz DL, Chang RT, Knight OJ, Feuer WJ. Macular Ganglion cell–inner plexiform layer: automated detection and thickness reproducibility with spectral domain–optical coherence tomography in Glaucoma. Invest Ophthalmol Vis Sci. 2011;52:8323–9.

Article  PubMed  PubMed Central  Google Scholar 

Alexander GC, Emerson S, Kesselheim AS. Evaluation of aducanumab for Alzheimer disease: scientific evidence and regulatory review involving efficacy, safety, and futility. JAMA. 2021;325:1717–8.

Article  PubMed  Google Scholar